by admin | May 20, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Legislation is headed to President’s desk for signature May 19, 2021 – The U.S. Senate has unanimously approved re-authorization of the National Cord Blood Inventory (NCBI) at up to $23 million annually through Fiscal Year 2026. The Senate sponsors of the...
by admin | May 18, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Will Lead Business Development Activities After 14 Years as Executive Director of Maryland Stem Cell Research Fund MIAMI, May 18, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage...
by admin | May 14, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
BOCA RATON, Fla., May 14, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Noble Capital Markets (“Noble”), a research-driven investment bank, today announces its platinum-level sponsorship of, and collaboration with, the 16th World Stem Cell Summit, to be held...
by admin | May 10, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
COLUMBIA, Md. (May 10, 2021)—The Maryland Stem Cell Research Commission has approved funding to its second-round of 2021 recipients for a total of $6,052,901. The Commission has also appointed Amritha Jaishankar, Ph.D., the current MSCRF Director – Programs...
by admin | May 4, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Durham, NC – A study released today in STEM CELLS Translational Medicine offers hope for those suffering from a chronic, difficult to treat condition called non-tuberculous mycobacteria (NTM) lung infection. The study describes how researchers at Case Western...
by admin | Apr 28, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
MIAMI, April 27, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions,...